Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 141,320 | 122,235 | 116,169 | 94,014 | 93,678 |
| Depreciation Amortization | 45,956 | 49,773 | 47,984 | 40,958 | 29,816 |
| Income taxes - deferred | -908 | 3,270 | 5,634 | -9,075 | -6,135 |
| Accounts receivable | -6,914 | -1,155 | -10,266 | -25,535 | -6,583 |
| Accounts payable and accrued liabilities | 3,482 | -9,156 | -4,327 | 5,851 | 4,352 |
| Other Working Capital | -3,135 | -10,300 | -33,511 | -1,010 | -10,236 |
| Other Operating Activity | -968 | 20,285 | 21,625 | 29,921 | 4,934 |
| Operating Cash Flow | $178,833 | $174,952 | $143,308 | $135,124 | $109,826 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 35,000 | 30,655 |
| PPE Investments | -38,796 | -48,584 | -89,971 | -65,138 | -44,415 |
| Net Acquisitions | N/A | -4,537 | 3,134 | N/A | N/A |
| Purchase Of Investment | -4,000 | 0 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -394 | -500 | -4,758 | -89,884 | -25,220 |
| Other Investing Activity | -394 | -500 | -4,758 | -90,990 | -26,940 |
| Investing Cash Flow | $-43,190 | $-53,621 | $-91,595 | $-121,128 | $-40,700 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,143 | -32,830 | 79,550 | 72,389 | N/A |
| Common Stock Issued | 28,865 | 16,366 | 16,360 | 20,941 | 20,922 |
| Common Stock Repurchased | -143,090 | -83,099 | -132,342 | -118,387 | -105,711 |
| Other Financing Activity | 17,313 | 4,268 | 5,642 | 6,870 | 8,530 |
| Financing Cash Flow | $-86,769 | $-95,295 | $-30,790 | $-18,187 | $-76,259 |
| Exchange Rate Effect | 1,313 | 1,824 | -2,415 | 2,885 | 1,648 |
| Beginning Cash Position | 106,728 | 78,868 | 60,360 | 61,666 | 67,151 |
| End Cash Position | 156,915 | 106,728 | 78,868 | 60,360 | 61,666 |
| Net Cash Flow | $50,187 | $27,860 | $18,508 | $-1,306 | $-5,485 |
| Free Cash Flow | |||||
| Operating Cash Flow | 178,833 | 174,952 | 143,308 | 135,124 | 109,826 |
| Capital Expenditure | -38,908 | -50,663 | -89,971 | -65,138 | -44,415 |
| Free Cash Flow | 139,925 | 124,289 | 53,337 | 69,986 | 65,411 |